Importer of Controlled Substances Application: Cerilliant Corporation, 56631-56633 [2020-20159]

Download as PDF 56631 Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices agreements. All non-confidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. The Commission vote for these determinations took place on September 8, 2020. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: September 8, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–20122 Filed 9–11–20; 8:45 am] BILLING CODE 7020–02–P Drug Enforcement Administration [Docket No. DEA–713] Importer of Controlled Substances Application: Cerilliant Corporation Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 14, 2020. Such persons may also file a written request for a hearing on the application on or before October 14, 2020. SUMMARY: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: DEPARTMENT OF JUSTICE In accordance with 21 CFR 1301.34(a), this is notice that on July 23, 2020, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, applied to be registered as an importer of the following basic classes of controlled substance(s): SUPPLEMENTARY INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code 3-Fluoro-N-methylcathinone (3-FMC) .................................................................................................................................... Cathinone .............................................................................................................................................................................. Methcathinone ....................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4-FMC) .................................................................................................................................... Pentedrone (a-methylaminovalerophenone) ......................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .......................................................................................................................... 4-Methyl-N-ethylcathinone (4-MEC) ...................................................................................................................................... Naphyrone ............................................................................................................................................................................. N-Ethylamphetamine ............................................................................................................................................................. N,N-Dimethylamphetamine .................................................................................................................................................... Fenethylline ........................................................................................................................................................................... Methaqualone ........................................................................................................................................................................ JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ......................................................................................................... SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ....................................................... 5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone ..................... AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................ JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ............................................................................................................................. AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................ THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ....................................................................... AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...................... ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................ APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) .................................................................. JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ......................................................................................................... SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ........................................................................... JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................... JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................ UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ........................................................................ JWH-073 (1-Butyl-3-(1-naphthoyl)indole) .............................................................................................................................. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................................. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................ PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ........................................................................................................ 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................................... Alpha-ethyltryptamine ............................................................................................................................................................ Ibogaine ................................................................................................................................................................................. CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ....................................................................... CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................. Lysergic acid diethylamide .................................................................................................................................................... 2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ....................................................................................................... Marihuana .............................................................................................................................................................................. Parahexyl ............................................................................................................................................................................... Mescaline ............................................................................................................................................................................... 2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) .................................................................................................. 3,4,5-Trimethoxyamphetamine .............................................................................................................................................. VerDate Sep<11>2014 17:51 Sep 11, 2020 Jkt 250001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 2565 6250 7008 7011 7012 7019 7023 7024 7031 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 7315 7348 7360 7374 7381 7385 7390 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 56632 Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code 4-Bromo-2,5-dimethoxyamphetamine ................................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................ 4-Methyl-2,5-dimethoxyamphetamine ................................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................................. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................ 3,4-Methylenedioxyamphetamine .......................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................ N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................ 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................. 3,4-Methylenedioxymethamphetamine .................................................................................................................................. 4-Methoxyamphetamine ........................................................................................................................................................ 5-Methoxy-N-N-dimethyltryptamine ....................................................................................................................................... Alpha-methyltryptamine ......................................................................................................................................................... Bufotenine .............................................................................................................................................................................. Diethyltryptamine ................................................................................................................................................................... Dimethyltryptamine ................................................................................................................................................................ Psilocybin ............................................................................................................................................................................... Psilocyn ................................................................................................................................................................................. 5-Methoxy-N,N-diisopropyltryptamine ................................................................................................................................... N-Ethyl-1-phenylcyclohexylamine .......................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .......................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ..................................................................................................................................... N-Benzylpiperazine ................................................................................................................................................................ 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ........................................................................................................... 2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................ 2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................................ 2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) ......................................................................................................................... 2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................................ 2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .......................................................................................................... 2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ........................................................................................................... 2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .................................................................................................... 2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ........................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................. 25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................... 25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................... 25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................ Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................ Butylone ................................................................................................................................................................................. Pentylone ............................................................................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) .............................................................................................................................. alpha-pyrrolidinobutiophenone (a-PBP) ................................................................................................................................ AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .......................................................................................................... Desomorphine ....................................................................................................................................................................... Etorphine (except HCl) .......................................................................................................................................................... Codeine methylbromide ......................................................................................................................................................... Heroin .................................................................................................................................................................................... Morphine-N-oxide .................................................................................................................................................................. Normorphine .......................................................................................................................................................................... Pholcodine ............................................................................................................................................................................. U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..................................................................... AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................ Acetylmethadol ...................................................................................................................................................................... Allylprodine ............................................................................................................................................................................ Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................ Alphameprodine ..................................................................................................................................................................... Alphamethadol ....................................................................................................................................................................... Betacetylmethadol ................................................................................................................................................................. Betameprodine ...................................................................................................................................................................... Betamethadol ......................................................................................................................................................................... Betaprodine ........................................................................................................................................................................... Dextromoramide .................................................................................................................................................................... Dipipanone ............................................................................................................................................................................. Hydroxypethidine ................................................................................................................................................................... Noracymethadol ..................................................................................................................................................................... Norlevorphanol ...................................................................................................................................................................... Normethadone ....................................................................................................................................................................... Racemoramide ...................................................................................................................................................................... Trimeperidine ......................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................ Tilidine ................................................................................................................................................................................... Para-Fluorofentanyl ............................................................................................................................................................... 3-Methylfentanyl .................................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................................. Acetyl-alpha-methylfentanyl ................................................................................................................................................... VerDate Sep<11>2014 17:51 Sep 11, 2020 Jkt 250001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1 7391 7392 7395 7396 7398 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9055 9056 9070 9200 9307 9313 9314 9547 9551 9601 9602 9603 9604 9605 9607 9608 9609 9611 9613 9622 9627 9633 9634 9635 9645 9646 9661 9750 9812 9813 9814 9815 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 56633 Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices Controlled substance Drug code Beta-hydroxyfentanyl ............................................................................................................................................................. Beta-hydroxy-3-methylfentanyl .............................................................................................................................................. Alpha-methylthiofentanyl ....................................................................................................................................................... 3-Methylthiofentanyl ............................................................................................................................................................... Thiofentanyl ........................................................................................................................................................................... Fentanyl related-substances as defined in 21 CFR 1308.11(h) ........................................................................................... Methamphetamine ................................................................................................................................................................. Methylphenidate .................................................................................................................................................................... Amobarbital ............................................................................................................................................................................ Pentobarbital .......................................................................................................................................................................... Secobarbital ........................................................................................................................................................................... Glutethimide ........................................................................................................................................................................... Nabilone ................................................................................................................................................................................. 1-Phenylcyclohexylamine ...................................................................................................................................................... Phencyclidine ......................................................................................................................................................................... Phenylacetone ....................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ...................................................................................................................................... Alphaprodine .......................................................................................................................................................................... Dihydrocodeine ...................................................................................................................................................................... Ecgonine ................................................................................................................................................................................ Ethylmorphine ........................................................................................................................................................................ Levomethorphan .................................................................................................................................................................... Levorphanol ........................................................................................................................................................................... Meperidine ............................................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... Levo-alphacetylmethadol ....................................................................................................................................................... Noroxymorphone ................................................................................................................................................................... Racemethorphan ................................................................................................................................................................... Alfentanil ................................................................................................................................................................................ Remifentanil ........................................................................................................................................................................... Sufentanil ............................................................................................................................................................................... Carfentanil ............................................................................................................................................................................. Tapentadol ............................................................................................................................................................................. The company plans to import the listed controlled substances for the manufacturing of analytical reference standards and distribution to their research and forensic customers. Approval of permit application will occur only when the registrant’s activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2020–20159 Filed 9–11–20; 8:45 am] BILLING CODE P substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 13, 2020 Such persons may also file a written request for a hearing on the application on or before November 13, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.33(a), this is notice that on August 5, 2020, Organix Inc., 240 Salem Street, Woburn, Massachusetts 01801–2029, applied to be registered as a bulk manufacturer of the following basic class(es) of a controlled substance(s): SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Drug Enforcement Administration khammond on DSKJM1Z7X2PROD with NOTICES [Docket No. DEA–712] Bulk Manufacturer of Controlled Substances Application: Organix Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Organix Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled Controlled substance Drug code 5-Methoxy-N-Ndimethyltryptamine. 7431 Schedule I SUMMARY: VerDate Sep<11>2014 17:51 Sep 11, 2020 Jkt 250001 The company plans to synthesize the above-listed controlled substance for PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 9830 9831 9832 9833 9835 9850 1105 1724 2125 2270 2315 2550 7379 7460 7471 8501 8603 9010 9120 9180 9190 9210 9220 9230 9273 9648 9668 9732 9737 9739 9740 9743 9780 Schedule I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II distribution to its customers. No other activity for this drug code is authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–20162 Filed 9–11–20; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–709] Bulk Manufacturer of Controlled Substances Application: Cambridge Isotype Lab Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Cambridge Isotype Lab has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug(s) information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 13, 2020. Such SUMMARY: E:\FR\FM\14SEN1.SGM 14SEN1

Agencies

[Federal Register Volume 85, Number 178 (Monday, September 14, 2020)]
[Notices]
[Pages 56631-56633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20159]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-713]


Importer of Controlled Substances Application: Cerilliant 
Corporation

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cerilliant Corporation has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before October 14, 
2020. Such persons may also file a written request for a hearing on the 
application on or before October 14, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 23, 2020, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered 
as an importer of the following basic classes of controlled 
substance(s):

------------------------------------------------------------------------
            Controlled substance              Drug code      Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).........        1233  I
Cathinone..................................        1235  I
Methcathinone..............................        1237  I
4-Fluoro-N-methylcathinone (4-FMC).........        1238  I
Pentedrone ([alpha]-                               1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)....        1248  I
4-Methyl-N-ethylcathinone (4-MEC)..........        1249  I
Naphyrone..................................        1258  I
N-Ethylamphetamine.........................        1475  I
N,N-Dimethylamphetamine....................        1480  I
Fenethylline...............................        1503  I
Methaqualone...............................        2565  I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)        6250  I
 indole).
SR-18 (Also known as RCS-8) (1-                    7008  I
 Cyclohexylethyl-3-(2-methoxyphenylacetyl)
 indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-            7011  I
 pentyl)1H-indol-3-yl] (2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-       7012  I
 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
 carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)....        7019  I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-       7023  I
 yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-        7024  I
 yl](naphthalen-1-yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-       7031  I
 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-             7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-       7048  I
 1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)        7081  I
 indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-       7104  I
 methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-         7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)         7122  I
 indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-           7144  I
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)....        7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-          7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)         7201  I
 indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)         7203  I
 indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-         7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-        7225  I
 1H-indole-3-carboxylate).
Alpha-ethyltryptamine......................        7249  I
Ibogaine...................................        7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-               7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                    7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................        7315  I
2C-T-7 (2,5-Dimethoxy-4-(n)-                       7348  I
 propylthiophenethylamine.
Marihuana..................................        7360  I
Parahexyl..................................        7374  I
Mescaline..................................        7381  I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)        7385  I
 ethanamine ).
3,4,5-Trimethoxyamphetamine................        7390  I

[[Page 56632]]

 
4-Bromo-2,5-dimethoxyamphetamine...........        7391  I
4-Bromo-2,5-dimethoxyphenethylamine........        7392  I
4-Methyl-2,5-dimethoxyamphetamine..........        7395  I
2,5-Dimethoxyamphetamine...................        7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)         7398  I
 indole).
3,4-Methylenedioxyamphetamine..............        7400  I
5-Methoxy-3,4-methylenedioxyamphetamine....        7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine....        7402  I
3,4-Methylenedioxy-N-ethylamphetamine......        7404  I
3,4-Methylenedioxymethamphetamine..........        7405  I
4-Methoxyamphetamine.......................        7411  I
5-Methoxy-N-N-dimethyltryptamine...........        7431  I
Alpha-methyltryptamine.....................        7432  I
Bufotenine.................................        7433  I
Diethyltryptamine..........................        7434  I
Dimethyltryptamine.........................        7435  I
Psilocybin.................................        7437  I
Psilocyn...................................        7438  I
5-Methoxy-N,N-diisopropyltryptamine........        7439  I
N-Ethyl-1-phenylcyclohexylamine............        7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..........        7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine......        7470  I
N-Benzylpiperazine.........................        7493  I
4-MePPP (4-Methyl-                                 7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)             7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)              7509  I
 ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)...        7517  I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl)                7518  I
 ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl)              7519  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)             7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)         7524  I
 ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                   7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)......        7535  I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-        7536  I
 N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-       7537  I
 N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-       7538  I
 (2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                   7540  I
 methylcathinone).
Butylone...................................        7541  I
Pentylone..................................        7542  I
alpha-pyrrolidinopentiophenone ([alpha]-           7545  I
 PVP).
alpha-pyrrolidinobutiophenone ([alpha]-PBP)        7546  I
AM-694 (1-(5-Fluoropentyl)-3-(2-                   7694  I
 iodobenzoyl) indole).
Desomorphine...............................        9055  I
Etorphine (except HCl).....................        9056  I
Codeine methylbromide......................        9070  I
Heroin.....................................        9200  I
Morphine-N-oxide...........................        9307  I
Normorphine................................        9313  I
Pholcodine.................................        9314  I
U-47700 (3,4-dichloro-N-[2-                        9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                       9551  I
 dimethylamino)cyclohexylmethyl]benzamide)).
Acetylmethadol.............................        9601  I
Allylprodine...............................        9602  I
Alphacetylmethadol except levo-                    9603  I
 alphacetylmethadol.
Alphameprodine.............................        9604  I
Alphamethadol..............................        9605  I
Betacetylmethadol..........................        9607  I
Betameprodine..............................        9608  I
Betamethadol...............................        9609  I
Betaprodine................................        9611  I
Dextromoramide.............................        9613  I
Dipipanone.................................        9622  I
Hydroxypethidine...........................        9627  I
Noracymethadol.............................        9633  I
Norlevorphanol.............................        9634  I
Normethadone...............................        9635  I
Racemoramide...............................        9645  I
Trimeperidine..............................        9646  I
1-Methyl-4-phenyl-4-propionoxypiperidine...        9661  I
Tilidine...................................        9750  I
Para-Fluorofentanyl........................        9812  I
3-Methylfentanyl...........................        9813  I
Alpha-methylfentanyl.......................        9814  I
Acetyl-alpha-methylfentanyl................        9815  I

[[Page 56633]]

 
Beta-hydroxyfentanyl.......................        9830  I
Beta-hydroxy-3-methylfentanyl..............        9831  I
Alpha-methylthiofentanyl...................        9832  I
3-Methylthiofentanyl.......................        9833  I
Thiofentanyl...............................        9835  I
Fentanyl related-substances as defined in          9850  I
 21 CFR 1308.11(h).
Methamphetamine............................        1105  II
Methylphenidate............................        1724  II
Amobarbital................................        2125  II
Pentobarbital..............................        2270  II
Secobarbital...............................        2315  II
Glutethimide...............................        2550  II
Nabilone...................................        7379  II
1-Phenylcyclohexylamine....................        7460  II
Phencyclidine..............................        7471  II
Phenylacetone..............................        8501  II
1-Piperidinocyclohexanecarbonitrile........        8603  II
Alphaprodine...............................        9010  II
Dihydrocodeine.............................        9120  II
Ecgonine...................................        9180  II
Ethylmorphine..............................        9190  II
Levomethorphan.............................        9210  II
Levorphanol................................        9220  II
Meperidine.................................        9230  II
Dextropropoxyphene, bulk (non-dosage forms)        9273  II
Levo-alphacetylmethadol....................        9648  II
Noroxymorphone.............................        9668  II
Racemethorphan.............................        9732  II
Alfentanil.................................        9737  II
Remifentanil...............................        9739  II
Sufentanil.................................        9740  II
Carfentanil................................        9743  II
Tapentadol.................................        9780  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacturing of analytical reference standards and distribution to 
their research and forensic customers. Approval of permit application 
will occur only when the registrant's activity is consistent with what 
is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend 
to the import of Food and Drug Administration-approved or non-approved 
finished dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-20159 Filed 9-11-20; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.